Sangamo BioSciences | SGMO - Należności Handlowe





Należności Handlowe Zmiana Data
Alaunos Therapeutics USD 2K 0 2025-06
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Alterity Therapeutics Limited AUD 4.57M 1.42M 2025-12
Amgen USD 10.23B 1.09B 2026-06
Bayer EUR 18.7B 146M 2026-06
BioCryst Pharmaceuticals USD 110.76M 3.94M 2026-06
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Cipla INR 62.19B 12.42B 2026-03
Clal Biotechnology ILS 3.75M 186K 2022-12
Compugen USD 2.34M 44K 2026-03
CSL USD 4.32B 1.35B 2025-12
Gilead Sciences USD 5.06B 314M 2026-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
Grifols EUR 1B 285.88M 2025-12
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
J&J USD 22.54B 1.21B 2026-03
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
Merck USD 12.21B 435M 2026-03
Novartis USD 9.85B 252M 2026-06
Omeros USD 8.08M 440K 2024-06
Pfizer USD 16.19B 19M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 492M 10M 2026-06
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
Tectonic Therapeutic USD 0 270K 2023-12
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06